BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 11188893)

  • 1. [Ulcerated cutaneous lymphoma. 10 years of experience].
    Carbia SG; Hochman A; Dei-Cas I; Lagodin C; Melgar A; Allevato M; Woscoff A
    Medicina (B Aires); 2000; 60(5 Pt 1):565-9. PubMed ID: 11188893
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CD56+ lymphoma with skin involvement: clinicopathologic features and classification.
    Gniadecki R; Rossen K; Ralfkier E; Thomsen K; Skovgaard GL; Jønsson V
    Arch Dermatol; 2004 Apr; 140(4):427-36. PubMed ID: 15096371
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Subcutaneous panniculitis-like T-cell lymphoma presenting as venous stasis ulceration.
    Weenig RH; Daniel Su WP
    Int J Dermatol; 2006 Sep; 45(9):1083-5. PubMed ID: 16961516
    [No Abstract]   [Full Text] [Related]  

  • 4. The protean spectrum of non-Hodgkin lymphomas with prominent involvement of subcutaneous fat.
    Massone C; Lozzi GP; Egberts F; Fink-Puches R; Cota C; Kerl H; Cerroni L
    J Cutan Pathol; 2006 Jun; 33(6):418-25. PubMed ID: 16776717
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment results of tonsillar lymphoma: a 10-year experience.
    Mohammadianpanah M; Omidvai S; Mosalei A; Ahmadloo N
    Ann Hematol; 2005 Apr; 84(4):223-6. PubMed ID: 15042316
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fusariosis and skin T cell lymphoma: concomitant more than a differential diagnosis.
    Richetta AG; Lichtener M; Mattozzi C; Miccoli A; Giancristoforo S; D'Epiro S; Vullo V; Calvieri S
    Clin Ter; 2010; 161(3):265-7. PubMed ID: 20589360
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Overall survival in erythrodermic cutaneous T-cell lymphoma: an analysis of prognostic factors in a cohort of patients with erythrodermic cutaneous T-cell lymphoma.
    Vidulich KA; Talpur R; Bassett RL; Duvic M
    Int J Dermatol; 2009 Mar; 48(3):243-52. PubMed ID: 19261011
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-term follow-up of patients with early-stage cutaneous T-cell lymphoma who achieved complete remission with psoralen plus UV-A monotherapy.
    Querfeld C; Rosen ST; Kuzel TM; Kirby KA; Roenigk HH; Prinz BM; Guitart J
    Arch Dermatol; 2005 Mar; 141(3):305-11. PubMed ID: 15781671
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The spectrum of cutaneous lymphomas in patients less than 20 years of age.
    Fink-Puches R; Chott A; Ardigó M; Simonitsch I; Ferrara G; Kerl H; Cerroni L
    Pediatr Dermatol; 2004; 21(5):525-33. PubMed ID: 15461755
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Primary cutaneous lymphoproliferative disorders with dual lineage rearrangement.
    Kazakov DV; Kutzner H; Palmedo G; Boudova L; Michaelis S; Michal M; Vanecek T; Magro CM; Mukensnabl P; Dummer R; Burg G; Kempf W
    Am J Dermatopathol; 2006 Oct; 28(5):399-409. PubMed ID: 17012914
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Prognosis of primary cutaneous lymphomas].
    Grange F; Bagot M
    Ann Dermatol Venereol; 2002 Jan; 129(1 Pt 1):30-40. PubMed ID: 11937927
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Malignant T cell lymphoma associated with sarcoidosis.
    Harada H; Shijubo N; Katoh S; Satoh M; Abe S
    Sarcoidosis; 1994 Sep; 11(2):132-4. PubMed ID: 7809498
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Primary cutaneous diffuse large B-cell lymphoma, leg type: clinicopathologic features and prognostic analysis in 60 cases.
    Grange F; Beylot-Barry M; Courville P; Maubec E; Bagot M; Vergier B; Souteyrand P; Machet L; Dalac S; Esteve E; Templier I; Delaporte E; Avril MF; Robert C; Dalle S; Laroche L; Delaunay M; Joly P; Wechsler J; Petrella T
    Arch Dermatol; 2007 Sep; 143(9):1144-50. PubMed ID: 17875875
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Relative frequency of the different types of cutaneous T cell and natural killer cell lymphomas in Korea based on the proposed WHO classification and the EORTC classification.
    Chang SE; Jee MS; Kim KJ; Choi JH; Sung KJ; Moon KC; Koh JK
    J Dermatol; 2003 Jan; 30(1):42-7. PubMed ID: 12598708
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prolonged course of a cutaneous T-cell lymphoma with late systemic involvement.
    Ilan Y; Hillman M; Oren R; Kaufman B
    Br J Clin Pract; 1990 Dec; 44(12):731-3. PubMed ID: 2102216
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Subcutaneous panniculitis-like T-cell lymphoma: a clinicopathologic, immunophenotypic, and molecular study of 22 Asian cases according to WHO-EORTC classification.
    Kong YY; Dai B; Kong JC; Zhou XY; Lu HF; Shen L; Du X; Shi DR
    Am J Surg Pathol; 2008 Oct; 32(10):1495-502. PubMed ID: 18708940
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Extranodal nasal-type natural killer/T-cell lymphoma of the skin: a clinicopathologic study of 16 cases in China.
    Yu JB; Zuo Z; Tang Y; Zhao S; Zhang YC; Bi CF; Wang WY; Zhang WY; Wang L; Liu WP
    Hum Pathol; 2009 Jun; 40(6):807-16. PubMed ID: 19200574
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Treatment outcome and prognosis of 112 patients with nasal and nasopharyngeal peripheral T cell lymphomas].
    Zhang YJ; Ren ZM; Wu QL; He ZY; Huang Y; Xia YF; Lin TY; Cui NJ
    Zhonghua Xue Ye Xue Za Zhi; 2006 Apr; 27(4):217-21. PubMed ID: 16875549
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Non-Hodgkin's lymphomas of the skin].
    Sretenović M; Milivojević G; Donfrid M; Petrović Z; Nedeljkov-Janić R; Milojević M; Jovanović V; Bosković D; Petrović M
    Srp Arh Celok Lek; 1994; 122(3-4):75-8. PubMed ID: 17972814
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Analysis of T-cell receptor gene rearrangement for predicting clinical outcome in patients with cutaneous T-cell lymphoma: a comparison of Southern blot and polymerase chain reaction methods.
    Juarez T; Isenhath SN; Polissar NL; Sabath DE; Wood B; Hanke D; Haycox CL; Wood GS; Olerud JE
    Arch Dermatol; 2005 Sep; 141(9):1107-13. PubMed ID: 16172307
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.